Ascend is a series a startup based in United States. 2 investors tracked.
Based in the United Kingdom, Ascend is a startup. Its most recent tracked round is Series B. Brouky records 5 investors associated with the company.
Ascend offers biotechnology services including AAV manufacturing, analytical capabilities, and support for pre-clinical and clinical development, serving the gene therapy sector with CDMO services for therapy development and production.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.